| Preferred SDS: View |
| European information : |
| Most important hazard(s): |
| None - None found. |
S 02 - Keep out of the reach of children. S 22 - Do not breath dust. S 24/25 - Avoid contact with skin and eyes.
|
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD50 3580 mg/kg LIVER: OTHER CHANGES
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980.
oral-mouse LD50 10800 mg/kg LUNGS, THORAX, OR RESPIRATION: CYANOSIS
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980.
intraperitoneal-rat LD50 3900 mg/kg LIVER: OTHER CHANGES
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980.
oral-rat LD50 15000 mg/kg LUNGS, THORAX, OR RESPIRATION: CYANOSIS
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 11, Pg. 635, 1980.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|